As of 2026-09-27, the Fair Value of Cullinan Oncology Inc (CGEM) is -16.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 14.81 USD, the upside of Cullinan Oncology Inc is -212.44%.
With the market price of 14.81 USD and our fair value calculation, Cullinan Oncology Inc (CGEM) is not a good investment. Investing in CGEM stocks now will result in a potential loss of 212.44%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -51.80 | -65.57 | 111.21 | -153.16 | -167.38 | -65.34 |
| YoY growth | -150.73% | -26.58% | 269.61% | -237.72% | -9.28% | -30.94% |
| Market Cap (mil) | 1,169.21 |
| P/E | |
| Forward P/E |
| EPS | -3.33 |
| Avg earnings growth rate | -30.94% |
| TTM earnings | -204.69 |